Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.71 USD
-0.17%
Market Closed
Updated:
Apr 25, 2024
Abbott Laboratories
Cost of Revenue
|
Abbott Laboratories
Cost of Revenue Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Cost of Revenue
-$18.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cost of Revenue
-$11.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cost of Revenue
-$4.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-6%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cost of Revenue
-$1.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
|
|
Stryker Corp
NYSE:SYK
|
Cost of Revenue
-$7.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
See Also
What is Abbott Laboratories's Cost of Revenue?
Cost of Revenue
-18.1B
USD
-18.1B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Cost of Revenue amounts to -18.1B USD.
What is Abbott Laboratories's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-7%
-7%
Over the last year, the Cost of Revenue growth was 2%. The average annual Cost of Revenue growth rates for Abbott Laboratories have been -4% over the past three years , -7% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
